Articles > Newspapers > International Newspapers, Major Markets > Biotech Week articles > November 2009

Article: BioMarin to Present at the Oppenheimer Healthcare Conference.

Article from:
Biotech Week
Article date:
November 11, 2009
Copyright

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company update at the Oppenheimer Healthcare Conference in New York City on Tuesday, November 3, 2009 at 1:35 p.m. ET (see also BioMarin Pharmaceutical Inc.).

Interested parties may access a live audio webcast of the ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: New Report Analyzes Operations at BioMarin ...
M2 Presswire;  February 5, 2008 ;     700+ words ... ... Report Analyzes Operations at BioMarin Pharmaceutical, Developer of Biopharmaceuticals ... addition of Analysis of BioMarin Pharmaceutical to their offering. We present Analysis of BioMarin Pharmaceutical. A complete and comprehensive ...

Article: BioMarin Pharmaceutical (BMRN) SqueezeTrigger Price ...
M2 Presswire;  March 16, 2006 ;     700+ words ... ... 16 March 2006-BUYINS.NET: BioMarin Pharmaceutical (BMRN) SqueezeTrigger Price ... million shares declared short on BioMarin Pharmaceutical (NASDAQ: BMRN) have a SqueezeTrigger ... According to AP, investors in BioMarin Pharmaceutical responded to positive study results ...

Article: Research and Markets: New Report Analyzes Operations at ...
Business Wire;  February 6, 2008 ;     695 words ... ... has announced the addition of Analysis of BioMarin Pharmaceutical to their offering. We present Analysis of BioMarin Pharmaceutical. A complete and comprehensive analysis of BioMarin Pharmaceutical, includes an overview of the industry ...

Article: Investor Alert for BioMarin Pharmaceutical Inc.
M2 Presswire;  April 17, 2007 ;     700+ words ... ... Biotech News: Investor Alert for BioMarin Pharmaceutical Inc.(C)1994-2007 M2 COMMUNICATIONS ... success in the drug world, then BioMarin Pharmaceutical has been very successful. Two ... most up to date information on BioMarin Pharmaceutical Inc. are invited to sign up for ...

Article: BioMarin Pharmaceutical Inc. - Financial and ...
M2 Presswire;  May 6, 2009 ;     700+ words ... ... companiesandmarkets.com: BioMarin Pharmaceutical Inc. - Financial and Strategic ... com adds new report: BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review BioMarin Pharmaceutical Inc. - Financial and Strategic ...

Article: Vivakor, Inc. & Biomarin Pharmaceutical Inc. ...
M2 Presswire;  October 9, 2009 ;     700+ words ... ... com: Vivakor, Inc. & Biomarin Pharmaceutical Inc. Profiled By Markettelegraph ... 09102009 Vivakor, Inc. & BioMarin Pharmaceutical Inc. Profiled by MarketTelegraph ... Vivakor, Inc. (OTCBB: VIVK); BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) MarketTelegraph ...

Article: Progressive Following on BioMarin Pharmaceutical ...
M2 Presswire;  August 4, 2006 ;     700+ words ... ... com: Progressive Following on BioMarin Pharmaceutical Inc.(C)1994-2006 M2 COMMUNICATIONS ... of our current concentration on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and their ... process is to continually track BioMarin Pharmaceutical Inc. and use the information ...

Article: Fundamental Review for BioMarin Pharmaceutical Inc.
M2 Presswire;  February 20, 2007 ;     700+ words ... ... News: Fundamental Review for BioMarin Pharmaceutical Inc.(C)1994-2007 M2 COMMUNICATIONS ... in the drugmaking world, and BioMarin Pharmaceutical has been very successful. Two ... most up to date information on BioMarin Pharmaceutical Inc. are invited to sign up for ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives